Tomas Hode, PhD, Co-Founder, CIO, and President of Immunophotonics will be attending the AngioDynamics International Life Symposium from March 27th to 29th in Barcelona, Spain. This symposium unites industry partners and clinical experts from around the world, featuring diverse backgrounds, skills, and ideas, all aimed at exploring the latest breakthrough technologies in interventional oncology.
Be sure to look for Tomas at this event for an opportunity to find out more about how Immunophotonics innovative approach could transform routine tumor ablations into powerful immunotherapies with IP-001 turning every procedure into an opportunity to mobilize the body’s natural immune system against cancer.
